株式会社ユカリア Logo

株式会社ユカリア

Management, DX, and data solutions for healthcare and long-term care providers.

286A | T

Overview

Corporate Details

ISIN(s):
JP3946900002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目2番5号 霞が関ビルディング19階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Eucalia Inc. is a healthcare services company dedicated to transforming the medical and long-term care sectors. Its core business is providing management and operational support for hospitals and care facilities. The company offers a comprehensive suite of services, including management consulting, medical digital transformation (DX) solutions, and medical data utilization. Eucalia also directly operates facilities for the elderly. Its client base includes hospitals, care facilities, pharmaceutical companies, and academic institutions. The company operates on the principle of 'Sanpo-yoshi' (good for all three parties), aiming to build a sustainable ecosystem that improves the quality of life for facility management, healthcare workers, and patients alike, thereby strengthening the social infrastructure of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 09:21
Interim Report
確認書
Japanese 8.6 KB
2025-08-14 09:19
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 295.4 KB
2025-06-18 02:30
M&A Activity
臨時報告書
Japanese 20.2 KB
2025-06-05 09:46
M&A Activity
臨時報告書
Japanese 32.5 KB
2025-05-15 09:01
M&A Activity
臨時報告書
Japanese 30.0 KB
2025-05-15 07:43
M&A Activity
臨時報告書
Japanese 29.9 KB
2025-03-28 06:37
Post-Annual General Meeting Information
臨時報告書
Japanese 25.3 KB
2025-03-28 06:36
Registration Form
確認書
Japanese 8.6 KB
2025-03-28 06:36
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.3 KB
2025-03-28 06:35
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-02-17 02:05
M&A Activity
臨時報告書
Japanese 27.0 KB
2024-12-03 07:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.1 MB
2024-11-25 07:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.1 MB
2024-11-08 07:30
Registration Form
有価証券届出書(新規公開時)
Japanese 4.0 MB
2024-03-29 07:00
Foreign Filer Report
親会社等状況報告書(内国会社)-第19期(2023/01/01-2023/12/31)
Japanese 25.1 KB

Automate Your Workflow. Get a real-time feed of all 株式会社ユカリア filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社ユカリア

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社ユカリア via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QUINSTREET, INC Logo
AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.
United States of America
QNST
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978

Talk to a Data Expert

Have a question? We'll get back to you promptly.